Hale Karl J, Frigerio Mark, Manaviazar Soraya, Hummersone Marc G, Fillingham Ian J, Barsukov Igor G, Damblon Christian F, Gescher Andreas, Roberts Gordon C K
The Christopher Ingold Laboratories, University College London, 20 Gordon Street, London WC1H 0AJ, England.
Org Lett. 2003 Feb 20;5(4):499-502. doi: 10.1021/ol027392u.
[structure: see text] The synthesis of two truncated bryostatin analogues 2 and 3 is described. High-field NMR measurements on the C-ring analogue 3 in C(2)H(3)CN containing 25% (2)H(2)O have shown that it binds to the CRD2 of human PKC-alpha at virtually the same position as phorbol-13-acetate (PA) and bryostatin 1 (1). NMR titration studies have also revealed that 3 binds to the CRD2 with a potency similar in magnitude to PA but much less potently than 1.